Replies to post #322576 on Innovation Pharmaceuticals Inc (IPIX)

[olden_grumpini]

Per the PDF:

Received December 24, 2019; Accepted June 16, 2020

I'm guessing it was a year ago.

[chrismiss_everyday]

Paper presented last year...

https://library.ehaweb.org/eha/2019/24th/267712/roberta.napolitano.kevetrin.dampens.myc.expression.and.cellular.metabolism.in.html

“ Conclusion
Our results show kevetrin alters several key genes and cellular metabolism. Along with cellular data, this study could provide a rationale for an experimental trial in AML patients, especially those carrying TP53 mutation who actually have very few therapeutic options.”